Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by shoosh22on Aug 29, 2020 11:02am
149 Views
Post# 31475069

RE:RE:RE:RE:RE:RE:You clowns had better read this

RE:RE:RE:RE:RE:RE:You clowns had better read thiscottrader is right... Whoever use to write the NR should start doing it again.  We should all reach out to the company and express our dissatisfaction.  They have an obligation to protect Shareholder Value, and the last NR especially should have been explosive, but many compared those numbers to the 96% Validated by MRIGlobal, not fully comprehending that these tests were carried out in the Field.. any new test being tested in the Field will not be as accurate as an optimal labratory setting.  And they failed to discuss that this test will be for Asymptomatic people, To date the world does not have a good Rapid LF Antigen Test testing Aysymptomatic.  The other tests that only test people with symptoms of Covid well it doesn't take a brain surgeon to figure out why their test numbers pass.. just pass. until the Abbott test. which they claim is higher. 

Cottrader wrote:
I am agree entirely, been in since Feb, to keep it short the PRs(last 3) have been confusing, lacking context and the reason we aren't at previous or new highs.


<< Previous
Bullboard Posts
Next >>